Marino Garcia holds a stake in Dianthus Therapeutics, where he began as CEO in September 2023. Before this, he was involved in various leadership roles in the biopharmaceutical sector, leading to a wealth of experience. His holdings reflect his commitment...

Marino Garcia holds a stake in Dianthus Therapeutics, where he began as CEO in September 2023. Before this, he was involved in various leadership roles in the biopharmaceutical sector, leading to a wealth of experience. His holdings reflect his commitment to the company, but the significant changes in leadership and compensation metrics highlight a strategic shift at Dianthus. His previous positions, at Zealand Pharma and Synergy Pharmaceuticals, showcase his ability to drive growth. With a concentrated focus, Garcia’s net worth appears tied mainly to his role at Dianthus, emphasizing his investment in the firm’s future and success.